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ABSTRACT Analysis of the genome sequence of Streptomyces leeuwenhoekii C34T
identiﬁed biosynthetic gene clusters (BGCs) for three different lasso peptides (Lp1,
Lp2, and Lp3) which were not known to be made by the strain. Lasso peptides rep-
resent relatively new members of the RiPP (ribosomally synthesized and posttransla-
tionally modiﬁed peptides) family of natural products and have not been extensively
studied. Lp3, whose production could be detected in culture supernatants from S.
leeuwenhoekii C34T and after heterologous expression of its BGC in Streptomyces coe-
licolor, is identical to the previously characterized chaxapeptin. Lp1, whose produc-
tion could not be detected or achieved heterologously, appears to be identical to a
recently identiﬁed member of the citrulassin family of lasso peptides. Since produc-
tion of Lp2 by S. leeuwenhoekii C34T was not observed, its BGC was also expressed
in S. coelicolor. The lasso peptide was isolated and its structure conﬁrmed by mass
spectrometry and nuclear magnetic resonance analyses, revealing a novel structure
that appears to represent a new family of lasso peptides.
IMPORTANCE Recent developments in genome sequencing combined with bioinfor-
matic analysis have revealed that actinomycetes contain a plethora of unexpected
BGCs and thus have the potential to produce many more natural products than pre-
viously thought. This reﬂects the inability to detect the production of these com-
pounds under laboratory conditions, perhaps through the use of inappropriate
growth media or the absence of the environmental cues required to elicit expres-
sion of the corresponding BGCs. One approach to overcoming this problem is to cir-
cumvent the regulatory mechanisms that control expression of the BGC in its natural
host by deploying heterologous expression. The generally compact nature of lasso
peptide BGCs makes them particularly amenable to this approach, and, in the exam-
ple given here, analysis revealed a new member of the lasso peptide family of RiPPs.
This approach should be readily applicable to other cryptic lasso peptide gene clus-
ters and would also facilitate the design and production of nonnatural variants by
changing the sequence encoding the core peptide, as has been achieved with other
classes of RiPPs.
KEYWORDS Streptomyces, natural products, RiPP, lasso peptide, heterologous
expression
A group of strains belonging to the bacterial genus Streptomyces, subsequentlynamed Streptomyces leeuwenhoekii, were isolated from a sample collected from the
Chaxa Lagoon in the Salar de Atacama, an extreme environment located in northern
Chile (1, 2). These strains have been shown to produce a range of previously unknown
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natural products. For example, S. leeuwenhoekii C38 produces the polyketide atacamy-
cin (3); S. leeuwenhoekii C58 produces the lasso peptide chaxapeptin (4); S. leeuwen-
hoekii C79 produces four new specialized metabolites (H.-P. Fiedler, unpublished
results); and the type species, S. leeuwenhoekii C34T (2), produces two groups of
polyketides: the chaxamycins (5) and the chaxalactins (6). The chaxamycins and the
chaxalactins both possess antibacterial activity, while chaxamycin also displayed po-
tential anticancer activity by inhibiting the chaperone protein Hsp90; the atacamycins
show inhibitory activity toward phosphodiesterase PDE-4B2 (and thus may have anti-
inﬂammatory potential) and, in the case of atacamycin A, antiproliferative activity
against adeno carcinoma and breast carcinoma cells; chaxapeptin showed inhibitory
activity toward human lung cancer cell line A549. Thus, despite few studies, it appears
that streptomycetes (and probably other Actinobacteria) isolated from this extreme and
little-scrutinized ecological niche are likely to prove to be an abundant source of new
natural products with a range of potentially useful biological activities.
Our previous analysis of the genome sequence of S. leeuwenhoekii C34T revealed the
presence of 35 biosynthetic gene clusters (BGCs), including 3 encoding the putative
lasso peptides Lp1, Lp2, and Lp3 (7, 8). Lasso peptides have been isolated from a wide
range of bacteria, including Burkholderia, Caulobacter, Enterobacteriaceae, Rhodococcus,
and Streptomyces species derived from terrestrial, freshwater, and marine environments
(see reference 9 and references therein), although recent bioinformatic analysis sug-
gests a much broader phylogenetic distribution (10). They represent a growing class of
bioactive bacterial peptides, forming a subfamily within the much larger RiPP (ribo-
somally synthesized and posttranslationally modiﬁed peptides) family of natural prod-
ucts (11), and are characterized by a speciﬁc knotted structure, the lasso fold (12). Lasso
peptides are produced initially as precursor peptides with an N-terminal leader se-
quence and a C-terminal retained core region of 14 to 24 amino acid residues (13) that
contains a macrocyclic ring formed between the carboxylate side chain of an Asp or Glu
residue located at position 7, 8, or 9 of the core peptide and the amino group of the
N-terminal amino acid residue. While it was initially thought that there was a require-
ment for Gly to be the ﬁrst core peptide residue, examples of lasso peptides with
N-terminal Ala, Ser, and Cys have also been reported, and a recent bioinformatic
analysis revealed even greater ﬂexibility at this position (10). The C-terminal tail is
threaded through the macrocycle, presumably prior to ring closure, and is generally
retained in place sterically by the presence of C-terminal residues with bulky side chains
(although disulﬁde bonds play that role in some lasso peptides). The resulting highly
compact structure confers thermal stability and resistance to proteases and results in a
broad range of biological activities that include enzyme inhibition and receptor antag-
onism; some lasso peptides possess antibiotic activity (13). The unusual lasso structure,
which has thus far proved inaccessible to peptide synthesis, has also attracted attention
as a scaffold for epitope grafting (14), providing the opportunity to develop novel lasso
peptide-derived biological activities with therapeutic potential.
Lasso peptide biosynthesis requires a lasso cyclase (C-protein), homologous to
asparagine synthase, and a leader peptidase (B-protein), homologous to transglutami-
nase. Biosynthesis also requires a RiPP recognition element (RRE [an E-protein]; note
that we have adopted the nomenclature used in reference 10 for this protein, rather
than the previously used B1) which binds the leader peptide and directs enzymatic
modiﬁcation. In most cases (an exception is provided in this work), lasso peptide BGCs
also encode transporters for product export (15).
Here, we describe the analysis of three lasso peptide gene clusters of S. leeuwen-
hoekii C34T and the heterologous expression of two of them, leading to the chemical
characterization of one of the molecules, leepeptin, as a novel lasso peptide.
RESULTS
Identiﬁcation of three lasso peptide gene clusters in the S. leeuwenhoekii C34T
genome sequence. Three putative lasso peptide BGCs were identiﬁed in the genome
sequence of S. leeuwenhoekii C34T (7). These BGCs were not identiﬁed at the time by
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antiSMASH (16) but were revealed by searching initially for homologues of the lasso
cyclase, LarB, involved in lariatin biosynthesis in Rhodococcus jostii (GenBank accession
number BAL72547.1) (17) using blastP and the deduced proteome of S. leeuwenhoekii
C34T. Manual inspection of the genome sequences adjacent to identiﬁed homologues
revealed, in three cases, all of the enzymatic functions required for the biosynthesis of
three different lasso peptides. Moreover, the lack of substantial intergenic regions
suggested that all of the biosynthetic genes for each peptide might be contained in a
single transcription unit. A schematic representation of the BGCs is shown in Fig. 1.
While the BGCs for Lp1 and Lp2 are chromosomally located (GenBank accession
number LN831790), that for Lp3 occurs on pSLE2 (GenBank accession number
LN831789) and thus is potentially capable of lateral transfer by conjugation.
Identiﬁcation of Lp3 as chaxapeptin. Supernatants of S. leeuwenhoekii C34T
cultures grown in ﬁve different media were analyzed by matrix-assisted laser desorp-
tion ionization–time of ﬂight (MALDI-ToF) mass spectrometry (MS) for the production
of the expected peptides. When this work was initiated in early 2014, with the
exception of one example of the use of Cys (10), Gly was the only residue known to be
found at the N terminus of lasso core peptides; this apparent constraint inﬂuenced our
predictions of the size of the mature peptides made by each of the three BGCs. The Lp1
BGC encodes the precursor peptide MKKAYEAPTLVRLGSFRRKTGLLQRSGNDRLILSKN (the
core residues that we predicted, indicated in italics, would yield a molecule with an
accurate mass of 1,764.9959 Da after cyclization). The Lp2 BGC encodes the precursor
peptide MEHDEKTPYETPAVYGLGAFAEETGLYGVRNDEEINWHFDYWT (the initially pre-
dicted core sequence, in italics, would yield a molecule with an accurate mass of
2,395.0658 Da after cyclization). The Lp3 BGC encodes the precursor peptide MTELQP
EAYEAPSLIEVGEFSEDTLGFGSKPLDSFGLNFF (the predicted core residues, in italics, would
yield a molecule with an accurate mass of 1,613.7879 Da after cyclization). Ions with
masses matching those expected for Lp3 were readily detected and in high abundance
(see Fig. S1 in the supplemental material); we could not detect any ions corresponding
to the expected peptides for Lp1 and Lp2 or ions that could correspond to slightly
different peptides (e.g., one residue more or less if we had not predicted the core
peptide correctly).
Since Lp3 was readily detected in most of the culture media tested, we focused our
initial attention on this peptide. Sequencing of the peptide using liquid chromatogra-
phy–tandem high-resolution mass spectrometry (LC/tandem-HRMS) on a Synapt G2Si
FIG 1 Schematic representation of the three lasso peptide gene clusters of S. leeuwenhoekii C34T. Since the product
of the Lp1 gene cluster appears to be identical to one of the members of the citrulassin family of lasso peptides,
the genes have been named cit; similarly, since the product of the Lp3 gene cluster was shown to be chaxapeptin,
the genes have been named cxp.
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platform (Waters) revealed the expected sequence of the C-terminal tail and identiﬁed
the only aspartate in the core peptide as the residue likely to be involved in the
macrocyclization (Fig. S2), as we had predicted (we could not detect fragmentation of
the macrocycle, and so the last a, b, and y ions detected indicated the residue likely
involved in ring formation with the N-terminal NH2). These results, shown in more detail
in the supplemental material, led us to conclude that Lp3 is identical to chaxapeptin
produced by the closely related strain S. leeuwenhoekii C58 (4). Lp3 is also similar to
sungsanpin (11/15 identical core residues), which is produced by a marine actinomy-
cete, Streptomyces sp. strain SNJ013, that had been isolated from deep sea sediment
collected off the Korean coast (9). A blastP search of the GenBank database also
revealed homologues of Lp3 in the genome sequences of both Streptomyces kanamy-
ceticus (GenBank accession number WP_107099006) and Streptomyces cinnamoneus
(accession number WP_104531718) (Fig. S3).
Heterologous expression of the BGCs in S. coelicolor. The BGC for Lp3 is unusual
in that it does not contain any gene encoding a possible transporter; it was unclear to
us whether Lp3 could be secreted by ABC transporters encoded by the other two lasso
peptide BGCs or by a nonspeciﬁc transporter encoded somewhere else in the genome.
In contrast, the Lp2 BGC has two genes for possible ABC transporters, while that for Lp1
encodes a single ABC transporter. The three BGCs were cloned in the expression vector
pIJ10257 (18) downstream from the constitutive ermE* promoter (19) and were trans-
ferred to Streptomyces coelicolor expression hosts M1152 and M1154 (20) by conjuga-
tion (see the supplemental material for details).
We could readily detect Lp3 in culture supernatants of the heterologous hosts
containing the Lp3 expression construct pIJ12815 by both MALDI-ToF and liquid
chromatography–ion trap–time of ﬂight mass spectrometry (LC-IT-ToF MS) (Fig. S4); the
molecule had the same accurate mass and peptide sequence (determined by LC/
tandem-HRMS on a Waters Synapt G2Si platform) as Lp3 produced by S. leeuwenhoekii
C34T. Since S. coelicolor does not contain any lasso peptide BCGs, this result suggests
that export of Lp3 is not dependent on a dedicated lasso peptide transporter. We also
transferred pIJ12815 to Streptomyces albus J1074 and found that we could also readily
detect production of mature Lp3 in the culture supernatant (Fig. S4). These results
suggest that the secretion of mature Lp3 can be mediated by a nonspeciﬁc transporter
generally present in Streptomyces species.
The Lp2 BGC is also unusual in that the precursor peptide gene (leeA) lies down-
stream of the genes encoding biosynthetic activities (leeCEB) (Fig. 1). Our ﬁrst expres-
sion construct contained just leeCEBA transcribed from the constitutive ermE* promoter;
transfer to heterologous hosts S. coelicolor M1152 and M1154 failed to yield the
expected molecule or one of similar mass (data not shown). We then added the two
putative ABC transporter genes leeDF, reconstructing the native gene arrangement
(leeCEBADF; see Materials and Methods and Fig. S5 for details). Transfer of the resulting
pIJ12819 plasmid to S. coelicolor M1152 and M1154 resulted in the production of a
molecule (2,338.0440 Da) that was 57 Da lower in mass than that we had predicted for
Lp2 (2,395.0658 Da) (Fig. 2a). Structure elucidation of this molecule (see below) resolved
this anomaly and conﬁrmed that the observed molecule was the product of the Lp2
BGC (Fig. S11). These results indicated that, in contrast to Lp3 (chaxapeptin), the two
ABC transporters encoded within the BGC are required for peptide secretion (we did
not test whether one of the genes would sufﬁce).
Attempts to detect production of Lp1 by both S. leeuwenhoekii C34T (MALDI-ToF
analyses only; see Fig. S1) and S. coelicolor after introduction of the BCG (MALDI-ToF
and LC-IT-ToF MS analyses; data not shown) failed. However, multiple blastP searches
of the GenBank database performed using the predicted amino sequences of the Lp1
biosynthetic enzymes and ABC transporter as query sequences identiﬁed several
Streptomyces strains that could potentially produce a similar lasso peptide. Four of
these strains (Streptomyces viridochromogenes DSM 40736, Streptomyces davaonensis
JCM 4913, Streptomyces pristinaspiralis ATCC 25486, and Streptomyces roseochromoge-
Gomez-Escribano et al. Applied and Environmental Microbiology
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nes subsp. oscitans DS 12.976) were grown in a variety of different media, but we could
not detect any possible candidate peptides in culture supernatants. Since these at-
tempts were made, it has become apparent that the predicted core peptide of Lp1 is
identical to that of one of the members of the citrulassin family of lasso peptides
identiﬁed in reference 10. Interestingly, the study reported in reference 10 demon-
FIG 2 (a) Heterologous expression of the Lp2 BGC (contained in pIJ12819) in S. coelicolor M1152. Total ion chromatogram (TIC) and
zoomed-in full spectrum of the highlighted peak obtained by LC-IT-ToF MS (Shimadzu). The detected ion, [M 2H]2, with 1,170.0293m/z
suggests an observed neutral mass of 2,338.0440 Da for the monoisotopic molecule. (b) Possible core peptides deduced from the
nucleotide sequence of the leeA precursor peptide gene. Core peptides are shown in red and leader sequences in blue; the arrows indicate
possible cyclization events. (c) Ions expected and observed after LC/tandem-HRMS analysis of leepeptin. The table of expected ions was
calculated for the linear peptide after subtraction of a water molecule from the ions represented in panels b and a (using http://db
.systemsbiology.net:8080/proteomicsToolkit/FragIonServlet.html). The ions that were clearly detected are shaded in orange. The predicted
structure of leepeptin is shown in red at the bottom, with the green arrow indicating cyclization between Leu1 and Glu8 (the leader
sequence is shown in blue). Seq, sequence.
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strated that for family member citrulassin A, Arg9 of the core sequence (LLGLAGNDR
LVLSKN) is modiﬁed to citrulline. Arg9 is conserved across the large citrulassin family of
lasso peptides (10), suggesting that this unusual modiﬁcation may occur in many if not
all family members. As those published data established Lp1 as a member of a
previously identiﬁed class of lasso peptide, we abandoned further attempts to express
its BGC heterologously.
Characterization of Lp2 by liquid chromatography—high-resolution mass
spectrometry (LC-HRMS) and LC/tandem-HRMS. Heterologous expression of the Lp2
BGC in S. coelicolor produced a molecule with a mass of 2,338.0440 Da (the monoiso-
topic ion detected by LC-IT-ToF MS was 1,170.0293 m/z for [M 2H]2) (Fig. 2a). This
molecule was present in culture supernatants from all S. coelicolor M1152 and M1154
derivatives containing the Lp2 BGC but absent in samples from the host without the
BGC (in Fig. 2a, the negative control is M1152 carrying the Lp1 BGC). The Lp2 precursor
peptide (MEHDEKTPYETPAVYGLGAFAEETGLYGVRNDEEINWHFDYWT) could yield several
possible core peptides (Fig. 2b). At the time when we started this project in early 2014,
with the single exception of Cys (10), Gly was the only amino acid known to be used
to form the macrocyclic ring; consequently, we predicted two possible core peptides,
namely, GLYGVRNDEEINWHFDYWT, which would yield a molecule with an accurate
mass of 2,395.0658 Da after cyclization, and GVRNDEEINWHFDYWT, which would yield
a molecule with an accurate mass of 2,061.8970 Da after cyclization. However, analysis
of the molecule detected by LC-IT-ToF MS indicated that the core peptide was likely to
be LYGVRNDEEINWHFDYWT. This matched, within the accepted range of instrument
error, the predicted mass (2,338.0443 Da after cyclization) to the observed mass
(2,338.0440 Da). The partial sequence of the peptide was observed by LC/tandem-HRMS
on a Synapt G2Si platform (Waters); all the expected a, b, and y ions for the 10
C-terminal residues were clearly identiﬁed in the deconvoluted fragmentation spec-
trum (Fig. 2c; see also Fig. S6 and S7) conﬁrming that the heterologously produced
peptide was the product of the Lp2 BGC. We named this new natural product, with (at
the time) an unprecedented N-terminal Leu, leepeptin.
The LC/tandem-HRMS fragmentation data also allowed us to identify the internal
acidic residue likely to be involved in macrocyclization. Three acidic residues could
FIG 2 (Continued)
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potentially be involved based on the rules of lasso peptide macrocycle formation: Asp7,
Glu8, and Glu9 (positions refer to the core peptide). The last clearly detected frag-
ment ions were a9 (predicted, 1,030.4960; observed, 1,030.4958) and b9 (predicted,
1,058.4910; observed, 1,058.4921). We did not observe any ions that matched those
expected for the a8, b8, and y11 ions. Altogether, these results suggested that it is the
side chain of Glu8 that closes the macrocycle with the NH2 of the N-terminal Leu (Fig.
2c; see also Fig. S7).
NMR structure elucidation of leepeptin. All of the 1H and 13C nuclear magnetic
resonance (NMR) data were in agreement with in silico and MS predictions. Along with
one-dimensional (1D) experiments, 2D 1H-13C heteronuclear single quantum correlation
(HSQC), 1H-13C heteronuclear multiple-bond correlation (HMBC), 1H-1H total correlated
spectroscopy (TOCSY), 1H-13C HSQC-TOCSY, and 1H-1H nuclear Overhauser effect spectros-
copy (NOESY) allowed assignment of nearly all hydrogens (see Table S2 in the supplemen-
tal material) in the 18-residue peptide, including two Trp, two Tyr, two Asn, two Asp., two
Glu, one Leu, one Gly, one Val, one Arg, one Ile, one His, one Phe and one Thr.
Sequence connectivity was established using NOESY correlations (Fig. 3a). The
connection between Leu1 and Tyr2 was established using the correlations between
Leu1-NH and Tyr2-NH. The connection between Tyr2 and Gly3 was established using the
correlations among Tyr2-NH, H, H ( 2.35), and H ( 6.71) and Gly3-NH. Furthermore,
the Gly3-Val4 connection was determined using Gly3-NH to Val4-NH and Val4-H
correlations as well as the Gly3-H (all) to Val4-NH correlations. The Val4-Arg5 connec-
tion was determined using Val4-NH, H, H, and H ( 0.95) correlations (all) to Arg5-NH
correlations. The Arg5-Asn6 connection was established using Arg5-H and Asn6-H
correlations as well as Val4-H and H ( 0.95) connections to both Asn6-NH and
Asn6-H. Furthermore, the Asn6-Asp7 connection was determined using the Asn6-H
and Asp7-NH correlations. The Asp7-Glu8 connection was established using the Asp7-
NH, H, and H ( 2.27) correlations (all) to Glu8-NH and Asp7-NH to Glu8-H ( 1.75).
FIG 3 (a) NMR structure determination of leepeptin. Key NOESY correlations (blue) establishing sequence connec-
tivity between amino acid residues. (b) Stylized representation of leepeptin. Tail residues deduced to be plugs,
based on tail-to-ring NOE correlations, are displayed.
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The Glu8-Leu1 macrocyclization was determined through analysis of NOEs from Glu8-H
( 1.54) and H ( 1.67) to Leu1-H as well as Glu8-H ( 1.67) to Leu1-NH.
There is no NMR evidence for the sequence connectivities of Glu8-Glu9 and Glu9-
Ile10, but there is tandem MS (MS2) (Fig. 2c) evidence for these linkages. The Ile10-Asn11
connection was determined using the correlations between Ile10-NH to Asn11-H (
2.66) and Ile10-NH, H, H, H’s, and  ( 0.82) (all to Asn11-NH). Furthermore, the
Asn11-Trp12 connection was established using the correlations between Asn11-NH to
Trp12-NH and H ( 2.95). The Trp12-His13 connection was established using the
correlations from Trp12-H ( 2.95) and His13-NH. The His13-Phe14 connection was
determined using the correlations between His13-NH, H, and H ( 1.05) to Phe14-NH.
Furthermore, the Phe14-Asp15 connection was determined using the correlations be-
tween Phe14-H’s to Asp15-NH. The Asp15-Tyr16 connection was determined using the
correlation between Asp15-H and Tyr16-NH. The Tyr16-Trp17 connection was difﬁcult to
assign using NOEs due to overlapping chemical shifts of multiple residues with those
signals assigned in Trp17. The Tyr16- ( 6.38) correlation to Trp17-NH and the longer-
range correlation between Asp15-NH to Trp17-NH help to place this residue. Lastly, the
Trp17-Thr18 connection was established using the correlations between Trp-H, H’s,
and H ( 7.37) (all to Thr18-NH) as well as from Trp17-NH to Thr18-H.
NOESY data are generally used to conﬁrm the residues in class II lasso peptides that
prevent unthreading of the structure (see reference 15 for a discussion of the different
classes of lasso peptides). Purely on the basis of the number of NOE correlations from
tail residues back to macrocyclic residues, we were able to predict which amino acid
residues in the tail of the peptide play a role in locking the tail in place. Working from
the C-terminal Thr, Trp17 and Tyr16 each contain seven NOE correlations (Fig. S8). Both
of these two residues seem to act as lower plugs, in a “harpoon”-like fashion, which is
unusual among class II lasso peptides (Fig. 3b). Further up the tail, Phe14 contains seven
NOE correlations, suggesting that it acts as the upper plug (Fig. S8).
In an attempt to establish the absolute conﬁguration of the amino acid residues of
leepeptin, the methodology used in determining the absolute stereochemistry of chaxa-
peptin was followed (4). Marfey’s analysis was used to determine the L conformation for all
amino acids, with the exception of Leu1, Trp12 and Trp17 (overlapping peaks).
Leepeptin represents a new subfamily of lasso peptides. While we could not
detect any close homologues of leepeptin in the data set reported in reference 10,
blastP searches (21) of the GenBank database revealed four homologues encoded by
the genome sequences of Streptomyces sp. L-9-10, Micromonospora carbonacea, Amy-
colatopsis xylanica, and Actinomadura ﬁbrosa (Fig. 4). Generation of a sequence simi-
larity network (SSN) (22) using the precursor peptide sequences identiﬁed in Data Set
2 in reference 10 but also including these four newly identiﬁed sequences conﬁrmed
the emergence of this new subfamily of lasso peptides (Fig. S9). blastP searches of
precursor or core peptide data sets derived from reference 10 but also including these
four newly identiﬁed sequences and using the precursor and core sequences of each
of the ﬁve peptides as query sequences conﬁrmed the results of the SSN analyses; the
only signiﬁcant hits were other members of this new subfamily (data not shown).
FIG 4 Alignment of the amino acid sequences of the precursor peptide of leepeptin (GenBank accession number
CQR60041.1) with homologues found in the GenBank database, including Micromonospora carbonacea
(SCF49478.1), Streptomyces sp. L-9-10 (RYJ28011.1), Amycolatopsis xylanica (SDZ36359.1), and Actinomadura ﬁbrosa
(WP_131760281.1). Leader sequences are shown in blue and core peptide sequences in red.
Gomez-Escribano et al. Applied and Environmental Microbiology
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DISCUSSION
Analysis of the genome sequence of S. leeuwenhoekii C34T had revealed three BGCs
with the potential to produce the lasso peptides Lp1, Lp2, and Lp3 (7). Each of these
putative lasso peptides was also later identiﬁed at the sequence level in the bioinfor-
matic analysis reported in reference 10 but had not been characterized further. Lp3 was
shown in this work to be identical to the previously published chaxapeptin from the
closely related strain S. leeuwenhoekii C58, also isolated from the Chaxa Lagoon in the
Salar de Atacama. Production by S. leeuwenhoekii C34T and, after heterologous expres-
sion, by S. coelicolor was detected. Unusually, no transporters were encoded by the Lp3
BGC, and the results of our heterologous expression experiments suggest that export
of chaxapeptin is mediated by a nonspeciﬁc secretion system commonly present in
Streptomyces species; we are not aware of any other experimental reports of a lack of
a speciﬁc transporter for lasso peptide export. Genome sequence information is avail-
able for three of the four strains that possess genes encoding Lp3 homologues (see Fig.
S3 in the supplemental material); while neither of the BGCs identiﬁed in S. leeuwen-
hoekii C58 and in S. kanamyceticus encodes identiﬁable transporters, that present in S.
cinnamoneus encodes a two-component ABC transporter (data not shown). Why some
members of this newly identiﬁed family of lasso peptides should apparently utilize a
speciﬁc transporter while others do not is unknown.
Although we could not detect production of Lp1 by S. leeuwenhoekii C34T or elicit
its synthesis in S. coelicolor, the predicted product appears to be identical to a member
of the recently identiﬁed citrulassin family of lasso peptides (10).
Lp2, which appeared to represent a novel lasso peptide which we subsequently
named leepeptin, could not be detected in the culture supernatant of S. leeuwenhoekii
C34T but could be readily isolated after heterologous expression in S. coelicolor,
enabling its structural elucidation. Lack of production in the native strain but successful
expression of the Lp2 BCG in the heterologous host under the control of the consti-
tutive ermE* promoter presumably reﬂects lack of activation of the regulatory mecha-
nism required for leepeptin biosynthesis in S. leeuwenhoekii C34T under the growth
conditions used. This may indicate that a speciﬁc environmental signal that is required
to elicit leepeptin production in the native host was not provided under the experi-
mental conditions used. Leepeptin appears to represent a new subfamily of lasso
peptides. All three of the S. leeuwenhoekii C34T lasso peptides contain the conserved
leader sequence motif YxxPxLxxxGxxxxxTx, with the sole exception of the replacement
of Leu6 with Val in the leader peptide of leepeptin, and all three leader peptides possess
the “invariant” (with one known exception; see reference 10) Thr as the penultimate
amino acid residue (Fig. 5).
Lasso peptides are currently an understudied family of natural products. Although
the number of isolated compounds is relatively small (44 were identiﬁed in the supple-
mentary information of reference 10), genome mining has revealed gene clusters for
over 1,300 unique lasso peptides occurring across a wide range of bacterial genera (10).
Over 35% of these BGCs are found in Actinobacteria, and many may not be expressed
under laboratory conditions at the levels required for their detection. Consequently, we
believe that the approach of heterologous expression described here could provide a
useful means to unlock this untapped source of novel chemical diversity. Moreover, our
discovery of a structurally novel lasso peptide, leepeptin (whose biological activity
remains to be explored), in samples from the extreme environment of the Chaxa
Lagoon in the high-altitude Atacama Desert provides further support for the hypothesis
that the isolation of microorganisms from relatively little-explored environments such
as this may result in a plethora of new natural products.
MATERIALS AND METHODS
Strains, culture conditions, and general methods. Bacterial strains used and generated during this
study are listed in Table 1. Escherichia coli and Streptomyces strains were cultured, maintained, and
manipulated genetically following the methods described in reference 23 and reference 24, respectively.
Spore stocks of S. leeuwenhoekii were prepared following standard methods from cultures grown on
mannitol soya ﬂour (SFM) agar medium at 37°C for 5 to 7 days. The culture media used for lasso peptide
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production were as follows: R3 (25), TY (TSB [tryptone soya broth; Oxoid CM0129]–YEME [yeast extract-
malt extract; 24] [50:50]), LPM (Lariatin production medium) (17), LS (lassomycin seed medium) (26), and
modiﬁed ISP2 (5). Plasmids and oligonucleotides used or constructed during this work are listed in Table 2 and
Table S1 in the supplemental material, respectively. Molecular biology enzymes, reagents, and kits were used
according to the manufacturers’ instructions. High-ﬁdelity PCR ampliﬁcation was performed with Phusion or
Q5 DNA polymerases following the instructions of the manufacturer (NEB, Ipswich, MA) with nucleotide
proportions of 15A/15T/35G/35C to improve the ampliﬁcation efﬁciency of high-moles-percent (mol%) GC
Streptomyces DNA. Sanger sequencing was performed using the Euroﬁns Genomics service (Ebersberg,
Germany) and analyzed using the Staden package, version 2.0.0b9 (http://staden.sourceforge.net) (27). blastP
searches were performed at the NCBI server. Drawing of chemical structures and mass calculations were
performed with Accelrys Draw 4.1 SP1 (Accelrys Inc.) and ChemDraw Professional 18 (PerkinElmer, Inc.).
NMR data were analyzed with MestreNova V12 (Mestrelab Research S.L.).
Construction of pIJ12815. A 2.6-kb DNA fragment containing the BGC for Lp3 was PCR ampliﬁed
with primers JP127_NdeI (catATGGAACCCCAGATGACTGAG; introduced enzyme restriction sites here and
FIG 5 The three lasso peptides of S. leeuwenhoekii C34T. Leader sequences are shown in blue, with
conserved leader residues in green; core peptide sequences before and after proteolytic cleavage and
cyclization are shown in red.
TABLE 1 Bacterial strains used in this study
Strain Description Reference(s) and/or source(s)
E. coli DH5 Strain used for routine cloning 29
E. coli ET12567/pUZ8002 Methylation-deﬁcient strain used for conjugation with
Streptomyces; pUZ8002 provides conjugation
machinery
E. coli ET12567, 30; pUZ8002, David
Figurski, personal communication
S. leeuwenhoekii C34T Type strain 2
S. coelicolor M1152 M145, Δact Δred Δcpk Δcda rpoB[C1298T] 20
S. coelicolor M1154 M145, Δact Δred Δcpk Δcda rpoB[C1298T] rpsL[A262G] 20
S. albus J1074 S. albus G derivative J1074 (ilv-1 sal-2 R M) 31
S. viridochromogenes DSM 40736 Wild-type strain NCBI reference sequence; NZ_GG657757.1
S. pristinaspiralis ATCC 25486 Wild-type strain NCBI reference sequence; NZ_CM000950.1
S. davawensis JCM 4913 Wild-type strain 32 (strain also known as S. davaonensis
JCM 4913T)
S. roseochromogenes subsp. oscitans
DS 12.976
Wild-type strain 33
S. coelicolor M1623 S. coelicolor M1152/pIJ12819 This work
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below are underlined, and nucleotides not present in the genome sequence of S. leeuwenhoekii are
lowercase) and JP128_PacI (ttaattaaCGTGTCGACCGGTGTCAGG) and genomic DNA from S. leeuwenhoekii
C34T as the template. The PCR product was ﬁrst cloned into SmaI-digested pBluescript II KS() and the
sequence veriﬁed by Sanger sequencing with universal primers M13F-24mer (CGCCAGGGTTTTCCCAGT
CACGAC) and M13R-22mer (TCACACAGGAAACAGCTATGAC). The veriﬁed insertion from one clone was
excised with NdeI and PacI and cloned in pIJ10257 digested with the same enzymes, generating
pIJ12815. pIJ12815 was introduced into the heterologous Streptomyces expression hosts by conjugation
selecting for hygromycin-resistant integrants (24).
Construction of pIJ12819. A 2.8-kb DNA fragment containing the biosynthetic genes for Lp2
(leeCEBA) was PCR ampliﬁed with primers JP138_NdeI (aacatATGGAACCCTGCGTCCCG) and JP139_
HindIII (aaaagcttAGACCCTCATCCGCGCAATG) and genomic DNA from S. leeuwenhoekii C34T as the
template. Independently, a 3.8-kb DNA fragment containing the precursor peptide and transport genes
for Lp2 (leeADF) was PCR ampliﬁed with primers JP143_AvrII (aacctaggGCGGGGTGACCTGAGGTGGATG)
and JP144_NdeI (aacatATGGAGCACGACGAGAAGACG) and genomic DNA from S. leeuwenhoekii C34T as
the template. In both cases, the PCR product was ﬁrst cloned into SmaI-digested pBluescript II KS() and
the sequence veriﬁed by Sanger sequencing with universal primers M13F-24mer (CGCCAGGGTTTTCCC
AGTCACGAC) and M13R-22mer (TCACACAGGAAACAGCTATGAC). The leeADF fragment was excised by
digestion with BsiWI (internal to leeA) and NotI (provided by the vector polylinker) and ligated to the
pBluescript II KS() derivative containing leeCEBA cut with the same enzymes, reconstructing the
complete Lp2 leeCEBADF BGC (see Fig. S5 in the supplemental material). The insertion from one clone
was excised with NdeI and AvrII and cloned in pIJ10257 digested with the same enzymes, generating
pIJ12819. pIJ12819 was introduced into the heterologous Streptomyces expression hosts by conjugation
selecting for hygromycin-resistant integrants (24).
Large-scale production and puriﬁcation of leepeptin. S. coelicolor M1623 (S. coelicolor M1152
containing pIJ12819) was cultured in 25 ml of production medium (12.5 ml tryptone soya broth [TSB;
Difco]) plus 12.5 ml yeast extract-malt extract (YEME) broth (YEME composition per liter, 3 g yeast extract,
3 g malt extract, 5 g bacteriological peptone, 10 g glucose, and 170 g sucrose) in a 250-ml Erlenmeyer
ﬂask for 8 days. An aliquot of the culture was used to inoculate 150 ml TSB/YEME (50:50) in a 500-ml
Erlenmeyer ﬂask and grown for 7 days at 30°C and with shaking at 200 rpm. This culture was used to
inoculate ﬁve 2-liter bafﬂed Erlenmeyer ﬂasks containing 300 ml TSB/YEME (50:50) and incubated for
7 days at 30°C and with shaking at 200 rpm. The purity of the culture was veriﬁed at each step by
streaking out an aliquot of the culture on tryptic soy agar (Becton, Dickinson). The cultures were
harvested at 4,000 rpm for 10 min and the supernatant fractions pooled and mixed with 6% (wt/vol)
Diaion HP-20 resin beads (Mitsubishi) and left overnight. The resin beads were recovered by ﬁltering the
solution through glass wool and then soaked in methanol. The methanol fraction was ﬁltered through
ﬁlter paper in a vacuum system. The eluent was concentrated at 40°C at reduced pressure, and the
resulting solution was fractionated through an ion exchange column (Strata SAX) (55-m pore size, 70 Å,
500 mg/3 ml) using 10% of the packing weight as the loading fraction. The column was equilibrated with
20 column volumes of water before the sample was loaded and washed with 10 column volumes (30 ml)
of different mixtures of methanol-water solutions i to v as follows: (i) water; (ii) 75% water and 25%
methanol; (iii) 50% water and 50% methanol; (iv) 25% water and 75% methanol; (iv) 100% methanol; (v)
100% methanol and 0.1% triﬂuoroacetic acid (TFA). An aliquot of each fraction was concentrated and
analyzed by liquid chromatography-mass spectrometry (LC-MS), and the peptide was detected with highest
intensity in the fraction containing 75% methanol. This fraction was further concentrated and subjected to
semipreparative high-performance liquid chromatography (HPLC; Agilent 1200) through a C18 column
(Waters SunFire) (5-m particle size, 100-Å pore size, 250 by 10 mm) connected to a binary pump and a
photodiode array detector set at 280 nm. Solvents used were Milli-Q water–0.1% (vol/vol) formic acid (solvent
A) and methanol–0.1% (vol/vol) formic acid (solvent B). A gradient was set from 0% to 100% solvent B in
30min and then 100% solvent B for 5min, giving a total run time of 35min, with a ﬂow rate of 2ml/min. The
fraction containing the peptide eluted at around 22 to 23min. The puriﬁed peptide was obtained in a volume
of 3 mg, and the purity of the peptide was assessed by LC-MS (Fig. S10).
Mass spectrometric analyses. Values corresponding to the ions expected from peptide fragmen-
tation by tandem mass spectrometry (MS/MS) were calculated with Fragment Ion Calculator software
(http://db.systemsbiology.net:8080/proteomicsToolkit/FragIonServlet.html). For the calculation of A and
B ions, 18.0106 Da was deducted to account for the loss of a water molecule during cyclization. For
MALDI-ToF analyses, the peptide samples were spotted onto a prespotted AnchorChip MALDI target
plate (-cyano-4-hydroxycinnamic acid matrix; Bruker Daltonics, Coventry, United Kingdom), and the
spots were washed brieﬂy with 10 mM ammonium phosphate–0.1% TFA according to the manufacturer’s
instructions. After drying, the samples were analyzed using MALDI-ToF and an Ultraﬂex TOF/TOF mass
spectrometer (Bruker). The instrument was calibrated using the prespotted standards (ca. 200 laser
TABLE 2 Plasmids used and constructed during this study
Plasmid Description Reference or source
pBluescript II KS() General cloning vector 34
pIJ10257 Expression vector for Streptomyces, with ermE*p, hyg, conjugative
(oriT from RK2), integrative (phiC31 attP)
18
pIJ12815 pIJ10257 with the Lp3 BGC This work
pIJ12819 pIJ10257 with the complete Lp2 BGC This work
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shots). Samples were analyzed using a method optimized for peptide analysis, and spectra were
summed from ca. 30 15 laser shots. The data were processed in FlexAnalysis (Bruker). Several
liquid chromatography-mass spectrometry instruments and methods were employed. LC-IT-ToF MS
methods were performed as previously published (28); brieﬂy, samples were analyzed on a Shimadzu
NexeraX2 LC instrument ﬁtted with a Prominence photo diode array detector and with an LC-IT-ToF mass
spectrometer set for positive-ion-mode detection; samples were injected in a Kinetex XB-C18 column
(part no. 00B-4496-AN; Phenomenex, USA) (2.6-m particle size, 100-Å pore size, 50 by 2.10 mm) and
eluted with a gradient of 0.1% formic acid–water–methanol (2% to 100% methanol) over 9.5 min, at a
ﬂow rate of 0.6 ml per min; data acquisition and analysis were performed with LCMSsolution version 3
(Shimadzu). High-resolution mass spectra were acquired by LC-HRMS on a Synapt G2 mass spectrometer
equipped with an Acquity ultraperformance liquid chromatograph (UPLC; Waters, Wilmslow, United
Kingdom). Aliquots of the samples were injected onto an Acquity UPLC ethylene bridged hybrid (BEH)
C18 column (Waters) (1.7-m particle size, 100-Å pore size, 1 by 100 mm) and eluted with a gradient of
(solvent B) acetonitrile–0.1% formic acid mixed with (solvent A) water–0.1% formic acid with a ﬂow rate
of 0.4 ml/min at 45°C. The concentration of solvent B was kept at 3% for 1 min followed by a gradient
up to 50% solvent B in 12 min. MS data were collected with the following parameters: resolution mode;
positive-ion mode; scan time, 1 s; mass range, m/z 50 to 2,000 (calibrated with sodium formate); capillary
voltage, 3.0 kV; cone voltage, 40 V; source temperature, 150°C; desolvation temperature, 500°C. Leu-
enkephalin peptide was used to generate a lock-mass calibration with 556.2766 m/z measured every 10
s during the run. For MS/MS fragmentation, a data directed analysis (DDA) method was used with the
following parameters: precursor selection from inclusion list only (807.5; 1,170.5), MS/MS threshold, 7,000;
scan time, 5 s; no dynamic exclusion; collision energy (CE) ramped between 20 and 30 at low mass (m/z 50)
and 30 and 60 at high mass (m/z 2,000). HRMS was also performed on an Agilent Technology 1290 Inﬁnity
II system ﬁtted with a Kinetex C18 column (part no. 00D-4462-AN; Phenomenex Inc.) (2.6-m particle size,
100-Å pore size, 100 by 2.1mm), which was kept at 40°C. The system was coupled to a quadrupole time of
ﬂight (QTOF) maXis II mass spectrometer (Bruker Inc.). For liquid chromatography, a gradient of 95% Milli-Q
water to 100% solvent B (acetonitrile–0.1% formic acid) was used over 10min with a 5-l injection volume.
Mass spectrometry was deployed in positive-ionizationmode with amass/charge range of 50 to 2,000. MS/MS
fragmentation of puriﬁed leepeptin was obtained using direct injection into a LTQ XL Orbitrap mass
spectrometer using 35% relative collision energy. Marfey’s analysis was carried out using Marfey’s FDLA
[N-(2,4-dinitro-5-ﬂuorophenyl)-L-leucinylamide] standard (Sigma-Aldrich) and the protocol described in ref-
erence 4.
Nuclear magnetic resonance. All 1D and 2D NMR experiments were performed using a Bruker
Avance III HD 600-MHz spectrometer (Ascend 14.1 Tesla) with a Prodigy TCI cryoprobe at 25°C.
SUPPLEMENTAL MATERIAL
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